MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
52.92
+2.48 (4.92%)
At close: Aug 1, 2025, 4:00 PM
53.00
+0.08 (0.15%)
After-hours: Aug 1, 2025, 7:36 PM EDT

MLTX Stock Forecast

Stock Price Forecast

The 6 analysts that cover MLTX stock have a consensus rating of "Strong Buy" and an average price target of $73.33, which forecasts a 38.57% increase in the stock price over the next year. The lowest target is $61 and the highest is $100.

Price Target: $73.33 (+38.57%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$61$73.33$73$100
Change+15.27%+38.57%+37.94%+88.96%
* Price targets were last updated on Jun 3, 2025.

Analyst Ratings

The average analyst rating for MLTX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy333333
Buy344554
Hold111000
Sell000000
Strong Sell000000
Total788887

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Buy
Reiterates
$67
BuyReiterates$67+26.61%Jun 3, 2025
Wolfe Research
Wolfe Research
Buy
Upgrades
$61
BuyUpgrades$61+15.27%May 19, 2025
Needham
Needham
Strong Buy
Reiterates
$66
Strong BuyReiterates$66+24.72%May 13, 2025
Needham
Needham
Strong Buy
Reiterates
$66
Strong BuyReiterates$66+24.72%Apr 30, 2025
RBC Capital
RBC Capital
Buy
Initiates
$67
BuyInitiates$67+26.61%Mar 18, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.93
from -1.89
EPS Next Year
-3.70
from -2.93
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028
Revenue
------94.23M553.54M
Revenue Growth
-------487.47%
EPS
-8.21-1.70-0.73-1.89-2.93-3.70-3.890.30
EPS Growth
--------
Forward PE
-------178.90
No. Analysts
----1616125
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a192.1M
Avgn/an/a94.2M
Lown/an/a45.0M

Revenue Growth

Revenue Growth20252026202720282029
High---
Avg---
Low---

EPS Forecast

EPS20252026202720282029
High-2.29-2.42-2.61
Avg-2.93-3.70-3.89
Low-3.15-5.00-4.86

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.